Canine Pulmonary Carcinoma Survival Outcomes in Hong Kong

A retrospective study of 39 dogs with primary pulmonary carcinoma in Hong Kong, analyzing survival outcomes across different treatment modalities. The dataset includes categorized treatment groups and associated survival times, with results indicating significant survival differences between surgery, chemotherapy, and no-treatment groups.

Use Cases

• Compare median survival times across the 'surgery alone', 'surgery and chemotherapy', 'chemotherapy alone', and 'no treatment' groups.
• Analyze the progression free interval difference between 'maximum tolerated dose' and 'metronomic chemotherapy' protocols.
• Assess tumor-related mortality rates, which were highest in the 'no treatment' group.
• Evaluate the prevalence of 'advanced-stage diseases (stage III or above)' within the cohort of 39 dogs.

Strengths

• Includes 39 canine patient records with detailed treatment and outcome data.
• Provides specific survival metrics, such as a 568-day median survival time for the 'surgery alone' group.
• Reports comparative statistics, including a p-value < 0.001 for survival differences across treatment groups.

Limitations

• Small sample size of 39 dogs limits statistical power and generalizability.
• Data is retrospective, which may introduce selection bias compared to a prospective trial.
• Geographic scope is limited to Hong Kong, which may not represent canine populations elsewhere.

Provenance

Source

figshare, author Nicole Louie.

Collection Method

Retrospective clinical evaluation.

Time Range

null

Freshness

Last updated March 2026.

Geography

Hong Kong